CD8A and neoplasm: As their tumors are already inflamed with CD8+ T cells that seem to be held in check by multiple aspects of the tumor microenvironment, patients with HighCYT/HighICGscore may respond particularly well to immunotherapies, such as immune checkpoint blockade, that would remove the immunosuppressive signals hindering the CD8+ T cells from realizing their purpose.